nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—GRIK2—Parkinson's disease	0.401	0.539	CbGaD
Pentobarbital—CHRNA4—Parkinson's disease	0.343	0.461	CbGaD
Pentobarbital—CHRNA4—superior cervical ganglion—Parkinson's disease	0.00888	0.0836	CbGeAlD
Pentobarbital—CHRNA4—adrenal medulla—Parkinson's disease	0.00728	0.0685	CbGeAlD
Pentobarbital—GRIK2—cerebellar cortex—Parkinson's disease	0.00621	0.0585	CbGeAlD
Pentobarbital—GRIK2—telencephalic ventricle—Parkinson's disease	0.00361	0.034	CbGeAlD
Pentobarbital—CHRNA4—autonomic nervous system—Parkinson's disease	0.00326	0.0307	CbGeAlD
Pentobarbital—CHRNA4—telencephalic ventricle—Parkinson's disease	0.00291	0.0274	CbGeAlD
Pentobarbital—CHRNA4—peripheral nervous system—Parkinson's disease	0.00235	0.0221	CbGeAlD
Pentobarbital—GRIK2—nerve—Parkinson's disease	0.00228	0.0215	CbGeAlD
Pentobarbital—GRIA2—hindbrain—Parkinson's disease	0.00189	0.0178	CbGeAlD
Pentobarbital—CHRNA4—nerve—Parkinson's disease	0.00183	0.0172	CbGeAlD
Pentobarbital—GABRA6—hindbrain—Parkinson's disease	0.00183	0.0172	CbGeAlD
Pentobarbital—GRIK2—hindbrain—Parkinson's disease	0.00171	0.0161	CbGeAlD
Pentobarbital—CHRNA4—hindbrain—Parkinson's disease	0.00137	0.0129	CbGeAlD
Pentobarbital—GABRB2—hindbrain—Parkinson's disease	0.00134	0.0127	CbGeAlD
Pentobarbital—GABRA2—hindbrain—Parkinson's disease	0.00123	0.0116	CbGeAlD
Pentobarbital—GABRA1—hindbrain—Parkinson's disease	0.00119	0.0112	CbGeAlD
Pentobarbital—GRIA2—embryo—Parkinson's disease	0.00118	0.0111	CbGeAlD
Pentobarbital—GRIA2—brainstem—Parkinson's disease	0.00108	0.0102	CbGeAlD
Pentobarbital—GABRA6—brainstem—Parkinson's disease	0.00105	0.00985	CbGeAlD
Pentobarbital—GRIA2—forebrain—Parkinson's disease	0.00104	0.00984	CbGeAlD
Pentobarbital—GABRA5—forebrain—Parkinson's disease	0.000979	0.00922	CbGeAlD
Pentobarbital—GRIK2—brainstem—Parkinson's disease	0.000978	0.00921	CbGeAlD
Pentobarbital—CHRFAM7A—forebrain—Parkinson's disease	0.000952	0.00896	CbGeAlD
Pentobarbital—GRIK2—forebrain—Parkinson's disease	0.000944	0.00889	CbGeAlD
Pentobarbital—GABRA4—forebrain—Parkinson's disease	0.000888	0.00837	CbGeAlD
Pentobarbital—CHRNA4—brainstem—Parkinson's disease	0.000786	0.0074	CbGeAlD
Pentobarbital—GABRB2—brainstem—Parkinson's disease	0.00077	0.00725	CbGeAlD
Pentobarbital—CHRNA7—forebrain—Parkinson's disease	0.000769	0.00724	CbGeAlD
Pentobarbital—CHRNA4—forebrain—Parkinson's disease	0.000759	0.00714	CbGeAlD
Pentobarbital—GABRB2—forebrain—Parkinson's disease	0.000743	0.007	CbGeAlD
Pentobarbital—GABRG2—forebrain—Parkinson's disease	0.000743	0.007	CbGeAlD
Pentobarbital—GABRA2—brainstem—Parkinson's disease	0.000704	0.00662	CbGeAlD
Pentobarbital—GRIA2—midbrain—Parkinson's disease	0.00069	0.0065	CbGeAlD
Pentobarbital—GRIK2—medulla oblongata—Parkinson's disease	0.000682	0.00642	CbGeAlD
Pentobarbital—GABRA1—brainstem—Parkinson's disease	0.00068	0.0064	CbGeAlD
Pentobarbital—GABRA2—forebrain—Parkinson's disease	0.000679	0.00639	CbGeAlD
Pentobarbital—GRIA2—spinal cord—Parkinson's disease	0.000673	0.00634	CbGeAlD
Pentobarbital—GABRA1—forebrain—Parkinson's disease	0.000656	0.00618	CbGeAlD
Pentobarbital—CHRNA7—cardiovascular system—Parkinson's disease	0.00065	0.00612	CbGeAlD
Pentobarbital—CHRNA4—cardiovascular system—Parkinson's disease	0.000641	0.00604	CbGeAlD
Pentobarbital—GRIK2—midbrain—Parkinson's disease	0.000623	0.00587	CbGeAlD
Pentobarbital—GRIK2—spinal cord—Parkinson's disease	0.000608	0.00573	CbGeAlD
Pentobarbital—GRIA2—head—Parkinson's disease	0.000598	0.00563	CbGeAlD
Pentobarbital—GABRA6—head—Parkinson's disease	0.000578	0.00544	CbGeAlD
Pentobarbital—GABRB3—forebrain—Parkinson's disease	0.000571	0.00537	CbGeAlD
Pentobarbital—GRIA2—nervous system—Parkinson's disease	0.000567	0.00534	CbGeAlD
Pentobarbital—GABRA5—head—Parkinson's disease	0.000561	0.00528	CbGeAlD
Pentobarbital—GABRA6—nervous system—Parkinson's disease	0.000548	0.00516	CbGeAlD
Pentobarbital—GRIA2—central nervous system—Parkinson's disease	0.000546	0.00514	CbGeAlD
Pentobarbital—CHRFAM7A—head—Parkinson's disease	0.000545	0.00513	CbGeAlD
Pentobarbital—GRIK2—head—Parkinson's disease	0.000541	0.00509	CbGeAlD
Pentobarbital—GABRB2—medulla oblongata—Parkinson's disease	0.000537	0.00506	CbGeAlD
Pentobarbital—GABRG2—medulla oblongata—Parkinson's disease	0.000537	0.00506	CbGeAlD
Pentobarbital—Heptabarbital—GRIK2—Parkinson's disease	0.000537	0.065	CrCbGaD
Pentobarbital—GRIA2—cerebellum—Parkinson's disease	0.000534	0.00503	CbGeAlD
Pentobarbital—GABRA5—nervous system—Parkinson's disease	0.000532	0.00501	CbGeAlD
Pentobarbital—GABRA6—central nervous system—Parkinson's disease	0.000528	0.00497	CbGeAlD
Pentobarbital—GABRA3—head—Parkinson's disease	0.000522	0.00492	CbGeAlD
Pentobarbital—CHRFAM7A—nervous system—Parkinson's disease	0.000517	0.00487	CbGeAlD
Pentobarbital—GABRA6—cerebellum—Parkinson's disease	0.000516	0.00486	CbGeAlD
Pentobarbital—GRIK2—nervous system—Parkinson's disease	0.000512	0.00483	CbGeAlD
Pentobarbital—GABRA5—central nervous system—Parkinson's disease	0.000512	0.00482	CbGeAlD
Pentobarbital—GABRA4—head—Parkinson's disease	0.000509	0.00479	CbGeAlD
Pentobarbital—CHRNA4—midbrain—Parkinson's disease	0.000501	0.00472	CbGeAlD
Pentobarbital—CHRFAM7A—central nervous system—Parkinson's disease	0.000498	0.00469	CbGeAlD
Pentobarbital—GABRA3—nervous system—Parkinson's disease	0.000495	0.00466	CbGeAlD
Pentobarbital—GRIK2—central nervous system—Parkinson's disease	0.000493	0.00465	CbGeAlD
Pentobarbital—Butabarbital—GRIK2—Parkinson's disease	0.000491	0.0595	CrCbGaD
Pentobarbital—GABRB2—midbrain—Parkinson's disease	0.000491	0.00462	CbGeAlD
Pentobarbital—GABRG2—midbrain—Parkinson's disease	0.000491	0.00462	CbGeAlD
Pentobarbital—CHRNA4—spinal cord—Parkinson's disease	0.000489	0.0046	CbGeAlD
Pentobarbital—GABRA4—nervous system—Parkinson's disease	0.000482	0.00454	CbGeAlD
Pentobarbital—GRIK2—cerebellum—Parkinson's disease	0.000482	0.00454	CbGeAlD
Pentobarbital—GABRG2—spinal cord—Parkinson's disease	0.000479	0.00451	CbGeAlD
Pentobarbital—GABRB2—spinal cord—Parkinson's disease	0.000479	0.00451	CbGeAlD
Pentobarbital—GABRA3—central nervous system—Parkinson's disease	0.000477	0.00449	CbGeAlD
Pentobarbital—GABRA1—medulla oblongata—Parkinson's disease	0.000474	0.00446	CbGeAlD
Pentobarbital—Butethal—GRIK2—Parkinson's disease	0.000465	0.0564	CrCbGaD
Pentobarbital—GABRA4—central nervous system—Parkinson's disease	0.000464	0.00437	CbGeAlD
Pentobarbital—Heptabarbital—CHRNA4—Parkinson's disease	0.000459	0.0556	CrCbGaD
Pentobarbital—Butalbital—GRIK2—Parkinson's disease	0.000454	0.055	CrCbGaD
Pentobarbital—GABRA4—cerebellum—Parkinson's disease	0.000454	0.00427	CbGeAlD
Pentobarbital—Aprobarbital—GRIK2—Parkinson's disease	0.000448	0.0543	CrCbGaD
Pentobarbital—CHRNA7—head—Parkinson's disease	0.00044	0.00415	CbGeAlD
Pentobarbital—Thiopental—GRIK2—Parkinson's disease	0.000438	0.0531	CrCbGaD
Pentobarbital—CHRNA4—head—Parkinson's disease	0.000434	0.00409	CbGeAlD
Pentobarbital—GRIA2—brain—Parkinson's disease	0.000434	0.00408	CbGeAlD
Pentobarbital—GABRA1—midbrain—Parkinson's disease	0.000433	0.00408	CbGeAlD
Pentobarbital—Amobarbital—GRIK2—Parkinson's disease	0.000433	0.0524	CrCbGaD
Pentobarbital—GABRG2—head—Parkinson's disease	0.000426	0.00401	CbGeAlD
Pentobarbital—GABRB2—head—Parkinson's disease	0.000426	0.00401	CbGeAlD
Pentobarbital—GABRA1—spinal cord—Parkinson's disease	0.000423	0.00398	CbGeAlD
Pentobarbital—Butabarbital—CHRNA4—Parkinson's disease	0.00042	0.0509	CrCbGaD
Pentobarbital—GABRA6—brain—Parkinson's disease	0.000419	0.00394	CbGeAlD
Pentobarbital—CHRNA7—nervous system—Parkinson's disease	0.000417	0.00393	CbGeAlD
Pentobarbital—GABRB3—medulla oblongata—Parkinson's disease	0.000412	0.00388	CbGeAlD
Pentobarbital—CHRNA4—nervous system—Parkinson's disease	0.000412	0.00388	CbGeAlD
Pentobarbital—GABRA5—brain—Parkinson's disease	0.000406	0.00383	CbGeAlD
Pentobarbital—GABRG2—nervous system—Parkinson's disease	0.000403	0.0038	CbGeAlD
Pentobarbital—GABRB2—nervous system—Parkinson's disease	0.000403	0.0038	CbGeAlD
Pentobarbital—CHRNA7—central nervous system—Parkinson's disease	0.000402	0.00378	CbGeAlD
Pentobarbital—Butethal—CHRNA4—Parkinson's disease	0.000398	0.0482	CrCbGaD
Pentobarbital—CHRNA4—central nervous system—Parkinson's disease	0.000397	0.00373	CbGeAlD
Pentobarbital—CHRFAM7A—brain—Parkinson's disease	0.000395	0.00372	CbGeAlD
Pentobarbital—CYP2A6—cerebellum—Parkinson's disease	0.000393	0.0037	CbGeAlD
Pentobarbital—GRIK2—brain—Parkinson's disease	0.000392	0.00369	CbGeAlD
Pentobarbital—GABRA2—head—Parkinson's disease	0.000389	0.00366	CbGeAlD
Pentobarbital—GABRG2—central nervous system—Parkinson's disease	0.000388	0.00366	CbGeAlD
Pentobarbital—GABRB2—central nervous system—Parkinson's disease	0.000388	0.00366	CbGeAlD
Pentobarbital—Butalbital—CHRNA4—Parkinson's disease	0.000388	0.0471	CrCbGaD
Pentobarbital—CHRNA4—cerebellum—Parkinson's disease	0.000388	0.00365	CbGeAlD
Pentobarbital—Secobarbital—GRIK2—Parkinson's disease	0.000386	0.0467	CrCbGaD
Pentobarbital—Aprobarbital—CHRNA4—Parkinson's disease	0.000383	0.0464	CrCbGaD
Pentobarbital—GABRB2—cerebellum—Parkinson's disease	0.00038	0.00357	CbGeAlD
Pentobarbital—GABRG2—cerebellum—Parkinson's disease	0.00038	0.00357	CbGeAlD
Pentobarbital—GABRA3—brain—Parkinson's disease	0.000378	0.00356	CbGeAlD
Pentobarbital—GABRB3—midbrain—Parkinson's disease	0.000377	0.00355	CbGeAlD
Pentobarbital—GABRA1—head—Parkinson's disease	0.000376	0.00354	CbGeAlD
Pentobarbital—Thiopental—CHRNA4—Parkinson's disease	0.000375	0.0454	CrCbGaD
Pentobarbital—Amobarbital—CHRNA4—Parkinson's disease	0.00037	0.0448	CrCbGaD
Pentobarbital—GABRA4—brain—Parkinson's disease	0.000369	0.00347	CbGeAlD
Pentobarbital—GABRA2—nervous system—Parkinson's disease	0.000369	0.00347	CbGeAlD
Pentobarbital—GABRB3—spinal cord—Parkinson's disease	0.000368	0.00346	CbGeAlD
Pentobarbital—GABRA1—nervous system—Parkinson's disease	0.000356	0.00335	CbGeAlD
Pentobarbital—GABRA2—central nervous system—Parkinson's disease	0.000355	0.00334	CbGeAlD
Pentobarbital—GABRA2—cerebellum—Parkinson's disease	0.000347	0.00327	CbGeAlD
Pentobarbital—GABRA1—central nervous system—Parkinson's disease	0.000343	0.00323	CbGeAlD
Pentobarbital—GABRA1—cerebellum—Parkinson's disease	0.000335	0.00316	CbGeAlD
Pentobarbital—Talbutal—GRIK2—Parkinson's disease	0.000334	0.0405	CrCbGaD
Pentobarbital—Secobarbital—CHRNA4—Parkinson's disease	0.00033	0.04	CrCbGaD
Pentobarbital—GABRB3—head—Parkinson's disease	0.000327	0.00308	CbGeAlD
Pentobarbital—CHRNA7—brain—Parkinson's disease	0.000319	0.003	CbGeAlD
Pentobarbital—CYP2A6—brain—Parkinson's disease	0.000319	0.003	CbGeAlD
Pentobarbital—CHRNA4—brain—Parkinson's disease	0.000315	0.00296	CbGeAlD
Pentobarbital—GABRB3—nervous system—Parkinson's disease	0.00031	0.00292	CbGeAlD
Pentobarbital—GABRG2—brain—Parkinson's disease	0.000308	0.0029	CbGeAlD
Pentobarbital—GABRB2—brain—Parkinson's disease	0.000308	0.0029	CbGeAlD
Pentobarbital—GABRB3—central nervous system—Parkinson's disease	0.000298	0.00281	CbGeAlD
Pentobarbital—GABRB3—cerebellum—Parkinson's disease	0.000292	0.00275	CbGeAlD
Pentobarbital—Talbutal—CHRNA4—Parkinson's disease	0.000286	0.0346	CrCbGaD
Pentobarbital—GABRA2—brain—Parkinson's disease	0.000282	0.00265	CbGeAlD
Pentobarbital—GABRA1—brain—Parkinson's disease	0.000272	0.00256	CbGeAlD
Pentobarbital—Phenobarbital—GRIK2—Parkinson's disease	0.000272	0.033	CrCbGaD
Pentobarbital—GABRB3—brain—Parkinson's disease	0.000237	0.00223	CbGeAlD
Pentobarbital—Phenobarbital—CHRNA4—Parkinson's disease	0.000233	0.0282	CrCbGaD
Pentobarbital—Thiopental—CYP2E1—Parkinson's disease	0.000182	0.022	CrCbGaD
Pentobarbital—CYP3A4—nervous system—Parkinson's disease	0.000159	0.00149	CbGeAlD
Pentobarbital—CYP3A4—central nervous system—Parkinson's disease	0.000153	0.00144	CbGeAlD
Pentobarbital—Phenobarbital—CYP2E1—Parkinson's disease	0.000113	0.0137	CrCbGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.76e-05	0.000476	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	6.76e-05	0.000476	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HSPA8—Parkinson's disease	6.74e-05	0.000475	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	6.73e-05	0.000474	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—DLG4—Parkinson's disease	6.72e-05	0.000473	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.71e-05	0.000473	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	6.66e-05	0.000469	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—DLG4—Parkinson's disease	6.6e-05	0.000465	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	6.57e-05	0.000463	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—DLG4—Parkinson's disease	6.48e-05	0.000457	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	6.47e-05	0.000456	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	6.45e-05	0.000454	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—DLG4—Parkinson's disease	6.44e-05	0.000454	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	6.43e-05	0.000453	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.41e-05	0.000451	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTP1—Parkinson's disease	6.38e-05	0.000449	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	6.36e-05	0.000448	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	6.34e-05	0.000446	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—DLG4—Parkinson's disease	6.33e-05	0.000446	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	6.31e-05	0.000445	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	6.3e-05	0.000444	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—HMOX1—Parkinson's disease	6.29e-05	0.000443	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—COMT—Parkinson's disease	6.27e-05	0.000442	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	6.25e-05	0.00044	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	6.23e-05	0.000439	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—MAOA—Parkinson's disease	6.23e-05	0.000439	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	6.21e-05	0.000437	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—COMT—Parkinson's disease	6.19e-05	0.000436	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	6.18e-05	0.000436	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—MAOA—Parkinson's disease	6.15e-05	0.000433	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	6.13e-05	0.000432	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—CASP3—Parkinson's disease	6.13e-05	0.000432	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	6.09e-05	0.000429	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	6.08e-05	0.000429	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.05e-05	0.000426	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.97e-05	0.000421	CbGpPWpGaD
Pentobarbital—Phenobarbital—ABCB1—Parkinson's disease	5.92e-05	0.00718	CrCbGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	5.91e-05	0.000416	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HSPA8—Parkinson's disease	5.89e-05	0.000415	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	5.87e-05	0.000413	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—HGF—Parkinson's disease	5.86e-05	0.000413	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTM1—Parkinson's disease	5.86e-05	0.000413	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	5.84e-05	0.000411	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	5.78e-05	0.000407	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	5.7e-05	0.000401	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—COMT—Parkinson's disease	5.66e-05	0.000399	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—MAPK8—Parkinson's disease	5.63e-05	0.000397	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—MAOA—Parkinson's disease	5.62e-05	0.000396	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—COMT—Parkinson's disease	5.62e-05	0.000396	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTP1—Parkinson's disease	5.59e-05	0.000394	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.59e-05	0.000394	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—MAOA—Parkinson's disease	5.58e-05	0.000393	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.57e-05	0.000393	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—CP—Parkinson's disease	5.57e-05	0.000392	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—DLG4—Parkinson's disease	5.53e-05	0.00039	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—COMT—Parkinson's disease	5.5e-05	0.000388	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	5.5e-05	0.000387	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—MAOA—Parkinson's disease	5.46e-05	0.000385	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.46e-05	0.000385	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—COMT—Parkinson's disease	5.4e-05	0.000381	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	5.4e-05	0.000381	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—MAOA—Parkinson's disease	5.37e-05	0.000378	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	5.33e-05	0.000375	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—COMT—Parkinson's disease	5.31e-05	0.000374	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.31e-05	0.000374	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—COMT—Parkinson's disease	5.28e-05	0.000372	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—MAOA—Parkinson's disease	5.27e-05	0.000371	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—MAOA—Parkinson's disease	5.24e-05	0.000369	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.21e-05	0.000367	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—COMT—Parkinson's disease	5.18e-05	0.000365	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—MAOA—Parkinson's disease	5.14e-05	0.000362	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTM1—Parkinson's disease	5.14e-05	0.000362	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.12e-05	0.000361	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	5.12e-05	0.000361	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.09e-05	0.000358	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.03e-05	0.000354	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5e-05	0.000352	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.97e-05	0.00035	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	4.88e-05	0.000344	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	4.8e-05	0.000338	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	4.71e-05	0.000332	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	4.68e-05	0.00033	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	4.68e-05	0.00033	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	4.6e-05	0.000324	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—COMT—Parkinson's disease	4.53e-05	0.000319	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	4.52e-05	0.000319	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MAOA—Parkinson's disease	4.5e-05	0.000317	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.46e-05	0.000314	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.37e-05	0.000308	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	4.29e-05	0.000302	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	4.14e-05	0.000291	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	4.1e-05	0.000289	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.08e-05	0.000287	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.05e-05	0.000286	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	4.05e-05	0.000285	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.02e-05	0.000283	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.01e-05	0.000283	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.97e-05	0.000279	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	3.94e-05	0.000278	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.92e-05	0.000276	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	3.85e-05	0.000271	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.81e-05	0.000268	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.78e-05	0.000266	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.76e-05	0.000265	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	3.66e-05	0.000258	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MCCC1—Parkinson's disease	3.64e-05	0.000257	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ND3—Parkinson's disease	3.64e-05	0.000257	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.58e-05	0.000252	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.48e-05	0.000245	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.46e-05	0.000244	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.45e-05	0.000243	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.44e-05	0.000242	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TALDO1—Parkinson's disease	3.43e-05	0.000241	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—OMD—Parkinson's disease	3.43e-05	0.000241	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—COMT—Parkinson's disease	3.43e-05	0.000241	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.42e-05	0.000241	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	3.41e-05	0.00024	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	3.4e-05	0.00024	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	3.38e-05	0.000238	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	3.36e-05	0.000237	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.36e-05	0.000237	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.34e-05	0.000235	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.34e-05	0.000235	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.31e-05	0.000233	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.28e-05	0.000231	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.28e-05	0.000231	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.27e-05	0.00023	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.27e-05	0.00023	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NDUFB11—Parkinson's disease	3.25e-05	0.000229	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.22e-05	0.000227	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.2e-05	0.000226	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.18e-05	0.000224	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.15e-05	0.000222	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.14e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	3.13e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCH1—Parkinson's disease	3.1e-05	0.000218	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	3.09e-05	0.000218	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.99e-05	0.000211	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.9e-05	0.000205	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.87e-05	0.000202	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.86e-05	0.000202	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.85e-05	0.000201	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.8e-05	0.000197	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.79e-05	0.000196	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.78e-05	0.000196	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FBP1—Parkinson's disease	2.76e-05	0.000195	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—DBH—Parkinson's disease	2.76e-05	0.000195	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GBA—Parkinson's disease	2.76e-05	0.000195	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.75e-05	0.000194	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.74e-05	0.000193	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.73e-05	0.000193	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.72e-05	0.000192	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.69e-05	0.00019	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.68e-05	0.000189	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.67e-05	0.000188	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.62e-05	0.000185	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.51e-05	0.000177	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	2.49e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.45e-05	0.000173	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.39e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.36e-05	0.000166	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.29e-05	0.000162	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ND3—Parkinson's disease	2.22e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MCCC1—Parkinson's disease	2.22e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—OMD—Parkinson's disease	2.09e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TALDO1—Parkinson's disease	2.09e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.06e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.05e-05	0.000144	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.05e-05	0.000144	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.03e-05	0.000143	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—DDC—Parkinson's disease	2.03e-05	0.000143	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.03e-05	0.000143	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.02e-05	0.000142	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	1.98e-05	0.00014	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTA4—Parkinson's disease	1.91e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCH1—Parkinson's disease	1.89e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.88e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.86e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	1.72e-05	0.000121	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MAOB—Parkinson's disease	1.71e-05	0.00012	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.7e-05	0.00012	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—DBH—Parkinson's disease	1.68e-05	0.000119	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FBP1—Parkinson's disease	1.68e-05	0.000119	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GBA—Parkinson's disease	1.68e-05	0.000119	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ND3—Parkinson's disease	1.34e-05	9.41e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.34e-05	9.41e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	1.27e-05	8.93e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.26e-05	8.85e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—OMD—Parkinson's disease	1.26e-05	8.85e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CTGF—Parkinson's disease	1.24e-05	8.77e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—DDC—Parkinson's disease	1.24e-05	8.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.19e-05	8.39e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.17e-05	8.22e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	1.16e-05	8.17e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.15e-05	8.12e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—Parkinson's disease	1.15e-05	8.08e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.14e-05	8e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TH—Parkinson's disease	1.13e-05	7.96e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYCS—Parkinson's disease	1.09e-05	7.65e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.05e-05	7.4e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.04e-05	7.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—DBH—Parkinson's disease	1.01e-05	7.13e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.01e-05	7.13e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GBA—Parkinson's disease	1.01e-05	7.13e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.9e-06	6.98e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—COMT—Parkinson's disease	9.61e-06	6.77e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—Parkinson's disease	9.57e-06	6.74e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MAOA—Parkinson's disease	9.54e-06	6.72e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMOX1—Parkinson's disease	9.43e-06	6.65e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—Parkinson's disease	9.06e-06	6.38e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—Parkinson's disease	8.79e-06	6.19e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—Parkinson's disease	8.42e-06	5.93e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—Parkinson's disease	7.77e-06	5.47e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	7.73e-06	5.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CTGF—Parkinson's disease	7.59e-06	5.35e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—DDC—Parkinson's disease	7.43e-06	5.24e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOE—Parkinson's disease	7.23e-06	5.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	7.07e-06	4.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA4—Parkinson's disease	7.02e-06	4.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—Parkinson's disease	6.99e-06	4.93e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TH—Parkinson's disease	6.89e-06	4.86e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYCS—Parkinson's disease	6.62e-06	4.66e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.32e-06	4.45e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.26e-06	4.41e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—INS—Parkinson's disease	6.18e-06	4.35e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—COMT—Parkinson's disease	5.86e-06	4.13e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—Parkinson's disease	5.83e-06	4.11e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MAOA—Parkinson's disease	5.82e-06	4.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMOX1—Parkinson's disease	5.75e-06	4.05e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—Parkinson's disease	5.52e-06	3.89e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—Parkinson's disease	5.36e-06	3.78e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—Parkinson's disease	5.13e-06	3.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—Parkinson's disease	4.74e-06	3.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.65e-06	3.28e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.56e-06	3.22e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOE—Parkinson's disease	4.41e-06	3.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.25e-06	3e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.21e-06	2.96e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TH—Parkinson's disease	4.14e-06	2.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.98e-06	2.8e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—INS—Parkinson's disease	3.77e-06	2.65e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COMT—Parkinson's disease	3.52e-06	2.48e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.51e-06	2.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.5e-06	2.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.46e-06	2.44e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.32e-06	2.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.22e-06	2.27e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.09e-06	2.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.85e-06	2.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOE—Parkinson's disease	2.65e-06	1.87e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—INS—Parkinson's disease	2.27e-06	1.6e-05	CbGpPWpGaD
